George Soros's AVLN Position Overview
George Soros (via Soros Fund Management LLC) currently holds 10,000 shares of Avalyn Pharma Inc. (AVLN) worth $329,200, representing 0.00% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.
Based on recent 13F filings, George Soros has initiated a new position in AVLN, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
George Soros's Avalyn Pharma (AVLN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Avalyn Pharma (AVLN) Trades by George Soros
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +10,000 | New Buy | 10,000 | $32.92 |
George Soros's Avalyn Pharma Investment FAQs
George Soros first purchased Avalyn Pharma Inc. (AVLN) in Q2 2026, acquiring 10,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
George Soros has held Avalyn Pharma Inc. (AVLN) for 1 quarters since Q2 2026.
George Soros's largest addition to Avalyn Pharma Inc. (AVLN) was in Q2 2026, adding 10,000 shares worth $329,200.
According to the latest 13F filing for Q2 2026, George Soros's firm, Soros Fund Management LLC, owns 10,000 shares of Avalyn Pharma Inc. (AVLN), valued at approximately $329,200.
As of the Q2 2026 filing, Avalyn Pharma Inc. (AVLN) represents approximately 0.00% of George Soros's publicly disclosed stock portfolio, making it one of their key holdings.
George Soros's peak holding in Avalyn Pharma Inc. (AVLN) was 10,000 shares, as reported at the end of Q2 2026.